These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 11715688)

  • 1. [Cost effective and efficient? Pharmacoeconomic aspects of treatment with bisphosphonates].
    Krämer I
    Pharm Unserer Zeit; 2001; 30(6):542-7. PubMed ID: 11715688
    [No Abstract]   [Full Text] [Related]  

  • 2. Is treatment of early postmenopausal women with bisphosphonates justified?
    Epstein S
    Int J Clin Pract; 2007 Jun; 61(6):963-71. PubMed ID: 17504359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From effective to economical. The value of good osteoporosis therapy].
    Minne HW; Pfeifer M; Pollähne W
    MMW Fortschr Med; 2002 May; 144(21):30-3. PubMed ID: 12134421
    [No Abstract]   [Full Text] [Related]  

  • 4. [Osteoporosis treatment in Portugal: trends and geographical variation].
    Rocha O; Lunet N; Costa L; Barros H
    Acta Med Port; 2006; 19(5):373-80. PubMed ID: 17376323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated approach: bisphosphonate management for the treatment of osteoporosis.
    Owens G; Jackson R; Lewiecki EM
    Am J Manag Care; 2007 Dec; 13 Suppl 11():S290-308; quiz S309-12. PubMed ID: 18095779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Positive list of drugs and osteoporosis].
    Krankenpfl J; 2003; 41(4-6):113. PubMed ID: 12929324
    [No Abstract]   [Full Text] [Related]  

  • 7. [The necessity of cost-effectiveness analysis in osteoporosis].
    Lamy O; Krieg MA
    Rev Med Suisse; 2007 Jun; 3(115):1521-5. PubMed ID: 17682796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the impact of new UK guidelines on the management of aromatase inhibitor-associated bone loss.
    Sowden E; Evans B; Greenbank CM; Bukhari M; Halsey JP
    Rheumatology (Oxford); 2009 Feb; 48(2):197-8. PubMed ID: 19043085
    [No Abstract]   [Full Text] [Related]  

  • 9. [Geriatric prevention. Bisphosphonates in the treatment of osteoporosis].
    Minne HW
    Pharm Unserer Zeit; 2001; 30(6):512-7. PubMed ID: 11715684
    [No Abstract]   [Full Text] [Related]  

  • 10. [The successful development of bisphosphonates in the therapy of osteoporosis].
    Fassbender WJ; Stumpf UC; Kurth A
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs.
    Adler RA; Hochberg MC
    Arch Intern Med; 2003 Nov; 163(21):2619-24. PubMed ID: 14638562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteoporosis in patients under treatment for cancer and the possibilities for prevention and treatment].
    Eekhoff EM; Pinedo HM; Lips P
    Ned Tijdschr Geneeskd; 2007 Jun; 151(25):1388-93. PubMed ID: 17668601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utilisation and expenditure of medicines for the prophylaxis and treatment of osteoporosis.
    McGowan B; Bennett K; Barry M; Canny M
    Ir Med J; 2008 Feb; 101(2):38-41. PubMed ID: 18450246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The search for good compliance: economic aspects of a conveyed combination pharmaco-therapy, exemplified by an osteoporosis therapy.
    Oberender P; Zerth J
    Eur J Health Econ; 2008 May; 9(2):127-36. PubMed ID: 17447094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaw: balancing the benefits and risks of oral bisphosphonate treatment for osteoporosis.
    Jeffcoat M; Watts NB
    Gen Dent; 2008; 56(1):96-102; quiz 103-4, 111-2. PubMed ID: 18254568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
    Earnshaw SR; Graham CN; Ettinger B; Amonkar MM; Lynch NO; Middelhoven H
    Curr Med Res Opin; 2007 Oct; 23(10):2517-29. PubMed ID: 17825128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates and bone turnover in premenopausal women receiving adjuvant chemotherapy.
    Paterson A; Baker T
    J Clin Oncol; 2009 Mar; 27(7):1005-6. PubMed ID: 19171701
    [No Abstract]   [Full Text] [Related]  

  • 18. The benefits and costs of bisphosphonates.
    Coleman RE
    J Support Oncol; 2007; 5(10):483-4. PubMed ID: 18240670
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphosphonates effective in preventing bone complications associated with androgen deprivation therapy.
    J Support Oncol; 2006 Feb; 4(2):99-100. PubMed ID: 16499137
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonates: providing strength to a significant class.
    Ettinger B
    Manag Care; 2005 May; 14(5 Suppl):24-8. PubMed ID: 15962834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.